Study links Actos with delayed dementia

Share this article:

Diabetes medication Actos could be repurposed for Alzheimer's disease. Reuters reports that a clinical trial indicates that the “cheap generic treatment” appears to be associated with delayed onset of the memory-eating disease.

Reuters notes that earlier studies indicated this may be a potential benefit, but this latest trial was a heftier effort, based on German healthcare data from 2004 through 2010 across a data set that included 146,000 patients ages 60 and older who did not initially show signs of dementia.

Researchers found that 13,841 patients eventually suffered dementia but the risk was reduced for every three months patients took Actos.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.